Neumarkt in the Upper Palatinate, 4th May 2021– Dr. Uwe Baumann, Head of Global Business, left Bionorica SE on the 30th April 2021. He joined the company in 2004 as the Head of Marketing and Sales and was responsible for the Global Business division since 2005.
Neumarkt, March 5, 2021 – In the 2020 financial year, Bionorica SE, which is active in over 40 countries, took a break during a growth phase that has lasted for many years. The manufacturer of herbal medicines from the Upper Palatinate was confronted with extraordinary challenges in many pharmaceutical markets due to the COVID-19 pandemic. State-mandated social distancing and hygiene measures, the wearing of masks, remote work regulations and lockdowns led to an almost complete absence of the usual waves of respiratory illnesses
Neumarkt in the Upper Palatinate, 21/01/2022 – Bionorica appoints Dr Marco Linari to the Executive Board leading the Global Business. Dr Linari, who holds a doctorate in biochemistry, will thus be responsible for all marketing and sales activities at Bionorica worldwide as of April 1, 2022. “With more than 20 years of expertise in the pharmaceutical sector, his leadership track record and international experience, Dr Marco Linari will be instrumental for the growth and further internationalisation of Bionorica. We look forward to having him on board,” says Professor Dr Michael A. Popp, owner and CEO of Bionorica.
Neumarkt in the Upper Palatinate, 6th May 2021 – This year, Bionorica is once again amongst the Axia Best Managed Companies and has, as in 2020 and 2011, received the quality seal for the best managed companies. The award was presented to the company in Neumarkt, Bavaria, by representatives of the management consultancy company Deloitte and the bank Credit Suisse.
